Corporate | Financial May 20, 2025

Annual General Meeting approves dividend of €1.20, all shareholder representatives confirmed

– CEO Dr Jean-Yves Parisot presents 2024 results
– Dividend of €1.20 per share approved
– All shareholder representatives on the Supervisory Board re-elected / Michael König continues as Chairman of the Board

Read more

Corporate | Financial May 19, 2025

The United Kingdom Competition & Markets Authority (CMA) is closing investigations against Symrise

CMA Investigation 51257 – Investigation under Chapter I Competition Act 1998

The CMA announced today on its website that it is closing its investigation against Symrise on suspicion of anti-competitive agreements with competitors.

Read more

Corporate | Financial April 29, 2025

Symrise delivers solid growth in Q1 and reaffirms outlook

— Achieved organic growth of 4.2%
— Delivered sales of €1.3 billion driven primarily by higher volumes
— Reaffirms full year 2025 guidance: Organic growth 5-7% / EBITDA margin around 21% / Business free cash flow around 14%
— Conducted strategic assessment of Chemicals Production activities

Read more

Corporate | Financial March 27, 2025

Symrise raises dividend and confirms outlook

— Dividend proposal of € 1.20 per share (2023: € 1.10) – 15th increase in succession
— Symrise confirms targets for 2025: Organic growth of 5-7 %
— Profitability (EBITDA margin) of around 21 % expected
— Executive Board contract of Dr. Stephanie Cossmann extended ahead of schedule until January 2030

Read more

Corporate | Financial January 30, 2025

Symrise achieves significant sales growth in 2024 with a strong increase in profitability

— Organic growth of 8.7% / Group sales increase by 5.7% to around €5 billion (2023: €4.7 billion)
— EBITDA of €1,033 million significantly above previous year's figure (2023: €903 million )
— EBITDA margin rises to 20.7% (2023: 19.1%)
— Net Income increased by 40.5% to €478 million / Earnings per Share increased to €3.42 (2023:…

Read more